ArticleBlood advances2017
Intragenic amplification of
Open access · goldAbstract read
In one paragraph
Article in Blood advances, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 34 citations in OpenAlex.
- A novelBlood science (Baltimore, Md.) · 2026Article
- Article
- Fast and sensitive detection of targeted gene fusions using frequency minimizers and fuzzy pattern matching with Fuzzion2.Cell reports methods · 2025Article
- Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients' outcome.Annals of hematology · 2025Article
- Review
- PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome.Leukemia · 2025Article
- Unraveling the Genetic Heterogeneity of Acute Lymphoblastic Leukemia Based on NGS Applications.Cancers · 2024Review
- Article
- Article
- Article
- Transcription factor networks link B-lymphocyte development and malignant transformation in leukemia.Genes & development · 2023Review
- Allelic complexity of KMT2A partial tandem duplications in acute myeloid leukemia and myelodysplastic syndromes.Blood advances · 2022Article
- Characterization of PAX5 intragenic tandem multiplication in pediatric B-lymphoblastic leukemia by optical genome mapping.Blood advances · 2022Article
- Review
- Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience.Radiology and oncology · 2021Article
- Advances in germline predisposition to acute leukaemias and myeloid neoplasms.Nature reviews. Cancer · 2021Review
- A New Treatment Strategy for Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report and Literature Review.OncoTargets and therapy · 2021Article
- B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients?Cancers · 2020Review
- Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol.Genes, chromosomes & cancer · 2020Article
- MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia.Scientific reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
34 authors at 20 institutions in 14 countries.
Claire SchwabLeukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
Karin NebralChildren's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria.
Lucy ChiltonLeukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
Cristina LeschiINSERM Unité Mixte de Recherché 1131, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris Sorbonne Cité, Paris, France.
Esmé WaandersDepartment of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Judith M BoerDepartment of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
Markéta ŽaliováDepartment of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany.
Rosemary SuttonChildren's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia.ORCID 0000-0002-0188-6005
Ingegerd Ivanov ÖfverholmClinical Genetics Section, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Kentaro OhkiDepartment of Pediatric Hematology and Oncology, National Center for Child Health and Development, Tokyo, Japan.ORCID 0000-0003-2838-4555
Yuka YamashitaClinical Research Center, Nagoya Medical Center, National Hospital Organization, Aichi, Japan.
Stefanie Groeneveld-KrentzDivision of Oncology and Hematology, Department of Pediatrics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Eva FroňkováChildhood Leukaemia Investigation Prague, Department of Pediatric Hematology/Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.ORCID 0000-0002-6900-8145
Marleen BakkusDepartment of Hematology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
Joelle TchindaPediatric Oncology, Children's Research Centre, University Children's Hospital Zürich, Zürich, Switzerland.ORCID 0000-0002-9450-2006
Thayana da Conceição BarbosaPediatric Hematology-Oncology Program, Research Center, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Grazia FazioCentro Ricerca Tettamanti, Clinica Pediatrica, Università di Milano-Bicocca, Monza, Italy.ORCID 0000-0001-7077-8422
Wojciech MlynarskiDepartment of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland.
Agata PastorczakDepartment of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland.
Giovanni CazzanigaCentro Ricerca Tettamanti, Clinica Pediatrica, Università di Milano-Bicocca, Monza, Italy.ORCID 0000-0003-2955-4528
Maria S Pombo-de-OliveiraPediatric Hematology-Oncology Program, Research Center, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Jan TrkaChildhood Leukaemia Investigation Prague, Department of Pediatric Hematology/Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.ORCID 0000-0002-9527-8608
Renate Kirschner-SchwabeDivision of Oncology and Hematology, Department of Pediatrics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Toshihiko ImamuraDepartment of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Gisela BarbanyClinical Genetics Section, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Martin StanullaDepartment of Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany.
Andishe AttarbaschiDepartment of Pediatric Hematology and Oncology, St Anna Children's Hospital, Medical University of Vienna, Austria; and.
Renate Panzer-GrümayerChildren's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria.
Roland P KuiperDepartment of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Monique L den BoerDepartment of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
Hélène CavéINSERM Unité Mixte de Recherché 1131, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris Sorbonne Cité, Paris, France.ORCID 0000-0003-2840-1511
Anthony V MoormanLeukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
Christine J HarrisonLeukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
Sabine StrehlChildren's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria.ORCID 0000-0002-0179-0628
Blood Cancer UK · GBSt Anna Children's Hospital · ATCharles University · CZInserm · FRInstituto Nacional de Câncer - INCA · BRKarolinska Institutet · SEMedical University of Lodz · PLRadboud University Nijmegen · NLUniversity of Milano-Bicocca · ITCharité - Universitätsmedizin Berlin · DEErasmus MC - Sophia Children’s Hospital · NLGerman Cancer Research Center · DEKyoto Prefectural University of Medicine · JPMedizinische Hochschule Hannover · DENational Center For Child Health and Development · JPNational Hospital Organization · JPStichting Kinderoncologie Nederland · NLUniversity Children's Hospital Zurich · CHUNSW Sydney · AUVrije Universiteit Brussel · BE
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intragenic
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.